Xi Wang, PhD

Lead Real-World Evidence (RWE) Epidemiologist
CVS Health

Poster(s):

• (A-046) A Study of Granulocyte-Colony Stimulating Factor (G-CSF) Reference and Biosimilar Products using Real World Data to Emulate a Target Trial for Switching: A Biologics and Biosimilars Collective Intelligence Consortium Experience
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (SLC-048) Association between COVID-19 and thrombotic events: using Super Learner algorithm combined with doubly robust methods.
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET

• (A-350) Baseline Characteristics of Patients Included in a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States: Results From an Interim Analysis
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-333) Incidence Rates of Safety Events of Interest in a Post-Approval Study of Pfizer-BioNTech Original Monovalent COVID-19 Vaccine in the United States: Primary Series Analysis
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-329) Safety Monitoring of Health Outcomes following Influenza Vaccination during the 2023–2024 Season among U.S. individuals aged 6 months through 64 years
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-331) Safety Monitoring of Multiple Health Outcomes following 2023–2024 COVID-19 Vaccination among Commercial Health Plan Enrollees Aged 6 Months–64 Years in the United States
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET